Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Making risky decisions to take drug: Effects of cocaine abstinence in cocaine users.

Foltin RW, Evans SM, Haney M, Carpenter K, Bedi G.

Pharmacol Biochem Behav. 2019 Feb;177:20-26. doi: 10.1016/j.pbb.2018.12.008. Epub 2018 Dec 22.

PMID:
30584902
2.

Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users.

Reed SC, Haney M, Manubay J, Campagna BR, Reed B, Foltin RW, Evans SM.

Pharmacol Biochem Behav. 2019 Jan;176:72-82. doi: 10.1016/j.pbb.2018.11.008. Epub 2018 Dec 4.

PMID:
30521833
3.

Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.

Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M.

Addict Biol. 2018 Oct 31. doi: 10.1111/adb.12664. [Epub ahead of print]

PMID:
30378231
4.

Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys.

Foltin RW, Evans SM.

Drug Alcohol Depend. 2018 Jul 1;188:318-327. doi: 10.1016/j.drugalcdep.2018.04.018. Epub 2018 May 25.

PMID:
29852449
5.

Sex differences in the anorexigenic effects of dexfenfluramine and amphetamine in baboons.

Foltin RW, Evans SM.

Exp Clin Psychopharmacol. 2018 Aug;26(4):335-340. doi: 10.1037/pha0000201. Epub 2018 May 24.

PMID:
29792471
6.

Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.

Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR.

Addict Biol. 2018 Apr 16. doi: 10.1111/adb.12621. [Epub ahead of print]

PMID:
29659126
7.

Self-administration of methamphetamine aerosol by male and female baboons.

Foltin RW.

Pharmacol Biochem Behav. 2018 May;168:17-24. doi: 10.1016/j.pbb.2018.03.005. Epub 2018 Mar 13.

PMID:
29545026
8.

A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.

Dakwar E, Nunes EV, Hart CL, Hu MC, Foltin RW, Levin FR.

Neuropharmacology. 2018 Nov;142:270-276. doi: 10.1016/j.neuropharm.2018.01.005. Epub 2018 Jan 5.

PMID:
29309770
9.

Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

Keith DR, Gunderson EW, Haney M, Foltin RW, Hart CL.

Drug Alcohol Depend. 2017 Sep 1;178:534-543. doi: 10.1016/j.drugalcdep.2017.04.036. Epub 2017 Jun 28.

10.

Assessment of the motivation to use artificial sweetener among individuals with an eating disorder.

Schebendach J, Klein DA, Mayer LES, Attia E, Devlin MJ, Foltin RW, Walsh BT.

Appetite. 2017 Feb 1;109:131-136. doi: 10.1016/j.appet.2016.11.026. Epub 2016 Nov 21.

11.

Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.

Evans SM, Foltin RW, Hicks MJ, Rosenberg JB, De BP, Janda KD, Kaminsky SM, Crystal RG.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:76-86. doi: 10.1016/j.pbb.2016.09.008. Epub 2016 Sep 30.

12.

Modafinil decreases cocaine choice in human cocaine smokers only when the response requirement and the alternative reinforcer magnitude are large.

Foltin RW, Haney M, Bedi G, Evans SM.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:8-13. doi: 10.1016/j.pbb.2016.08.009. Epub 2016 Sep 1.

13.

The reinforcing effect of exercise in anorexia nervosa: Clinical correlates and relationship to outcome.

Gianini LM, Klein DA, Call C, Mayer L, Foltin RW, Walsh BT, Wang Y, Wu P, Attia E.

Eat Disord. 2016 Oct-Dec;24(5):412-23. doi: 10.1080/10640266.2016.1198204. Epub 2016 Jun 27.

PMID:
27348805
14.

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial.

Dakwar E, Hart CL, Levin FR, Nunes EV, Foltin RW.

Mol Psychiatry. 2017 Jan;22(1):76-81. doi: 10.1038/mp.2016.39. Epub 2016 Apr 19.

15.

Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M.

Psychopharmacology (Berl). 2016 Jul;233(13):2469-78. doi: 10.1007/s00213-016-4298-6. Epub 2016 Apr 16.

16.

Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.

Bedi G, Shiffrin L, Vadhan NP, Nunes EV, Foltin RW, Bisaga A.

J Psychopharmacol. 2016 Apr;30(4):370-7. doi: 10.1177/0269881115626308. Epub 2016 Feb 26.

17.

Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment response.

Carpenter KM, Amrhein PC, Bold KW, Mishlen K, Levin FR, Raby WN, Evans SM, Foltin RW, Nunes EV.

Exp Clin Psychopharmacol. 2016 Apr;24(2):77-89. doi: 10.1037/pha0000063. Epub 2016 Feb 25.

PMID:
26914460
18.

Development of translational preclinical models in substance abuse: Effects of cocaine administration on cocaine choice in humans and non-human primates.

Foltin RW, Haney M, Rubin E, Reed SC, Vadhan N, Balter R, Evans SM.

Pharmacol Biochem Behav. 2015 Jul;134:12-21. doi: 10.1016/j.pbb.2015.03.023. Epub 2015 Apr 28.

19.

Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users.

Askalsky P, Kalapatapu RK, Foltin RW, Comer SD.

Am J Drug Alcohol Abuse. 2015 Mar;41(2):161-5. doi: 10.3109/00952990.2014.966197. Epub 2014 Oct 16.

20.

Self-reported attention and mood symptoms in cocaine abusers: relationship to neurocognitive performance.

Benedict ES, Gorman A, van Gorp W, Foltin RW, Vadhan NP.

Psychiatry Res. 2014 Nov 30;219(3):598-603. doi: 10.1016/j.psychres.2014.06.011. Epub 2014 Jun 14.

21.

Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

Hicks MJ, Kaminsky SM, De BP, Rosenberg JB, Evans SM, Foltin RW, Andrenyak DM, Moody DE, Koob GF, Janda KD, Ricart Arbona RJ, Lepherd ML, Crystal RG.

Hum Gene Ther Clin Dev. 2014 Mar;25(1):40-9. doi: 10.1089/humc.2013.231.

22.

Impact of social status and antidepressant treatment on neurogenesis in the baboon hippocampus.

Wu MV, Shamy JL, Bedi G, Choi CW, Wall MM, Arango V, Boldrini M, Foltin RW, Hen R.

Neuropsychopharmacology. 2014 Jul;39(8):1861-71. doi: 10.1038/npp.2014.33. Epub 2014 Feb 12.

23.

A decrement in probabilistic category learning in cocaine users after controlling for marijuana and alcohol use.

Vadhan NP, Myers CE, Benedict E, Rubin E, Foltin RW, Gluck MA.

Exp Clin Psychopharmacol. 2014 Feb;22(1):65-74. doi: 10.1037/a0034506. Epub 2013 Nov 4.

PMID:
24188172
24.

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.

O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP.

Pain. 2013 Nov;154(11):2324-34. doi: 10.1016/j.pain.2013.06.035. Review.

PMID:
24148704
25.

The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.

Dakwar E, Levin F, Foltin RW, Nunes EV, Hart CL.

Biol Psychiatry. 2014 Jul 1;76(1):40-6. doi: 10.1016/j.biopsych.2013.08.009. Epub 2013 Sep 12.

26.

Identifying novel phenotypes of vulnerability and resistance to activity-based anorexia in adolescent female rats.

Barbarich-Marsteller NC, Underwood MD, Foltin RW, Myers MM, Walsh BT, Barrett JS, Marsteller DA.

Int J Eat Disord. 2013 Nov;46(7):737-46. doi: 10.1002/eat.22149. Epub 2013 Jul 13.

27.

Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.

Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, Haney M, Foltin RW.

Neuropsychopharmacology. 2013 Nov;38(12):2427-38. doi: 10.1038/npp.2013.143. Epub 2013 Jun 5.

28.

Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.

Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW.

Neuropsychopharmacology. 2013 Jul;38(8):1557-65. doi: 10.1038/npp.2013.54. Epub 2013 Feb 26.

29.

Can the reinforcing value of food be measured in bulimia nervosa?

Schebendach J, Broft A, Foltin RW, Walsh BT.

Appetite. 2013 Mar;62:70-5. doi: 10.1016/j.appet.2012.11.009. Epub 2012 Nov 23.

30.

Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques.

Cooper ZD, Foltin RW, Evans SM.

Horm Behav. 2013 Jan;63(1):105-13. doi: 10.1016/j.yhbeh.2012.10.008. Epub 2012 Oct 23.

31.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox JD, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL.

Pain. 2012 Dec;153(12):2315-24. doi: 10.1016/j.pain.2012.07.035. Epub 2012 Sep 19.

32.

Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status.

Haney M, Bedi G, Cooper ZD, Glass A, Vosburg SK, Comer SD, Foltin RW.

Biol Psychiatry. 2013 Feb 1;73(3):242-8. doi: 10.1016/j.biopsych.2012.07.028. Epub 2012 Aug 29.

33.

The subjective effects of cocaine: relationship to years of cocaine use and current age.

Kalapatapu RK, Bedi G, Haney M, Evans SM, Rubin E, Foltin RW.

Am J Drug Alcohol Abuse. 2012 Nov;38(6):530-4. doi: 10.3109/00952990.2012.704461. Epub 2012 Jul 19.

34.

The behavioral pharmacology of anorexigenic drugs in nonhuman primates: 30 years of progress.

Foltin RW.

Behav Pharmacol. 2012 Sep;23(5-6):461-77. doi: 10.1097/FBP.0b013e3283566aa0. Review.

35.

A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.

Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M.

Addict Biol. 2013 Nov;18(6):993-1002. doi: 10.1111/j.1369-1600.2012.00461.x. Epub 2012 Jun 28.

36.

Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers.

Cooper ZD, Sullivan MA, Vosburg SK, Manubay JM, Haney M, Foltin RW, Evans SM, Kowalczyk WJ, Saccone PA, Comer SD.

Behav Pharmacol. 2012 Jun;23(3):271-9. doi: 10.1097/FBP.0b013e3283536d6f.

37.

Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.

Kirkpatrick MG, Gunderson EW, Johanson CE, Levin FR, Foltin RW, Hart CL.

Addiction. 2012 Apr;107(4):783-91. doi: 10.1111/j.1360-0443.2011.03706.x.

38.

Does anorexia nervosa resemble an addiction?

Barbarich-Marsteller NC, Foltin RW, Walsh BT.

Curr Drug Abuse Rev. 2011 Sep;4(3):197-200. Review.

39.

Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health.

Roux P, Tindall C, Fugon L, Murray J, Vosburg SK, Saccone P, Sullivan MA, Manubay JM, Cooper ZD, Jones JD, Foltin RW, Comer SD.

Addiction. 2012 Mar;107(3):642-9. doi: 10.1111/j.1360-0443.2011.03664.x.

40.

Substance use after participation in laboratory studies involving smoked cocaine self-administration.

Kalapatapu RK, Bedi G, Haney M, Evans SM, Rubin E, Foltin RW.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):162-7. doi: 10.1016/j.drugalcdep.2011.07.015. Epub 2011 Aug 15.

41.

Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans.

Kirkpatrick MG, Gunderson EW, Levin FR, Foltin RW, Hart CL.

Psychopharmacology (Berl). 2012 Jan;219(1):191-204. doi: 10.1007/s00213-011-2390-5. Epub 2011 Jul 12.

42.

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL.

Psychopharmacology (Berl). 2012 Jan;219(1):109-22. doi: 10.1007/s00213-011-2383-4. Epub 2011 Jun 30.

43.

Consumption of palatable food decreases the anorectic effects of serotonergic, but not dopaminergic drugs in baboons.

Foltin RW.

Physiol Behav. 2011 Jul 6;103(5):493-500. doi: 10.1016/j.physbeh.2011.04.004. Epub 2011 Apr 13.

44.

A pilot study of neurocognitive function in older and younger cocaine abusers and controls.

Kalapatapu RK, Vadhan NP, Rubin E, Bedi G, Cheng WY, Sullivan MA, Foltin RW.

Am J Addict. 2011 May-Jun;20(3):228-39. doi: 10.1111/j.1521-0391.2011.00128.x. Epub 2011 Mar 17.

45.

Aripiprazole maintenance increases smoked cocaine self-administration in humans.

Haney M, Rubin E, Foltin RW.

Psychopharmacology (Berl). 2011 Aug;216(3):379-87. doi: 10.1007/s00213-011-2231-6. Epub 2011 Mar 5.

46.

The effects of oral micronized progesterone on smoked cocaine self-administration in women.

Reed SC, Evans SM, Bedi G, Rubin E, Foltin RW.

Horm Behav. 2011 Feb;59(2):227-35. doi: 10.1016/j.yhbeh.2010.12.009. Epub 2010 Dec 28.

47.

Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.

Bedi G, Foltin RW, Gunderson EW, Rabkin J, Hart CL, Comer SD, Vosburg SK, Haney M.

Psychopharmacology (Berl). 2010 Dec;212(4):675-86. doi: 10.1007/s00213-010-1995-4. Epub 2010 Sep 8.

48.

Zolpidem does not serve as reinforcer in humans subjected to simulated shift work.

Kirkpatrick MG, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):168-71. doi: 10.1016/j.drugalcdep.2010.06.002. Epub 2010 Jul 23.

49.

Neurophysiological and cognitive effects of smoked marijuana in frequent users.

Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J, Foltin RW.

Pharmacol Biochem Behav. 2010 Sep;96(3):333-41. doi: 10.1016/j.pbb.2010.06.003. Epub 2010 Jun 18.

50.

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW.

Psychopharmacology (Berl). 2010 Aug;211(2):233-44. doi: 10.1007/s00213-010-1888-6. Epub 2010 Jun 3.

Supplemental Content

Loading ...
Support Center